Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial von Orlando, Valentina, Drubay, Damien, Lavaud, Pernelle, Faivre, Laura, Lesaunier, François, Delva, Remy, Gravis, Gwenaëlle, Rolland, Frédéric, Priou, Frank, Ferrero, Jean-Marc, Houede, Nadine, Mourey, Loic, Theodore, Christine, Krakowski, Ivan, Berdah, Jean-François, Baciuchka, Marjorie, Laguerre, Brigitte, Fléchon, Aude, Grosse-Goupil, Marine, Cojean-Zelek, Isabelle, Oudard, Stéphane, Labourey, Jean-Luc, Chinet-Charrot, Paule, Legouffe, Eric, Lagrange, Jean-Léon, Linassier, Claude, Deplanque, Gaël, Beuzeboc, Philippe, Davin, Jean-Louis, Martin, Anne-Laure, Brihoum, Meryem, Culine, Stéphane, Teuff, Gwénaël Le, Fizazi, Karim

Volltext

Systemic treatment for metastatic prostate cancer von Gravis, Gwenaelle

Volltext

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial von Motzer, Robert J., Robbins, Paul B., Powles, Thomas, Albiges, Laurence, Haanen, John B., Larkin, James, Mu, Xinmeng Jasmine, Ching, Keith A., Uemura, Motohide, Pal, Sumanta K., Alekseev, Boris, Gravis, Gwenaelle, Campbell, Matthew T., Penkov, Konstantin, Lee, Jae Lyun, Hariharan, Subramanian, Wang, Xiao, Zhang, Weidong, Wang, Jing, Chudnovsky, Aleksander, di Pietro, Alessandra, Donahue, Amber C., Choueiri, Toni K.

Volltext

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial von de Bono, Johann Sebastian, Dr, Oudard, Stephane, MD, Ozguroglu, Mustafa, MD, Hansen, Steinbjørn, MD, Machiels, Jean-Pascal, MD, Kocak, Ivo, MD, Gravis, Gwenaëlle, MD, Bodrogi, Istvan, MD, Mackenzie, Mary J, MD, Shen, Liji, PhD, Roessner, Martin, MS, Gupta, Sunil, MD, Sartor, A Oliver, MD

Volltext

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity von Pasero, Christine, Gravis, Gwenaëlle, Guerin, Mathilde, Granjeaud, Samuel, Thomassin-Piana, Jeanne, Rocchi, Palma, Paciencia-Gros, Maria, Poizat, Flora, Bentobji, Mélanie, Azario-Cheillan, Francine, Walz, Jochen, Salem, Naji, Brunelle, Serge, Moretta, Alessandro, Olive, Daniel

Volltext

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma von Auvray, Marie, Auclin, Edouard, Barthelemy, Philippe, Bono, Petri, Kellokumpu-Lehtinen, Pirkko, Gross-Goupil, Marine, De Velasco, Guillermo, Powles, Thomas, Mouillet, Guillaume, Vano, Yann-Alexandre, Gravis, Gwenaëlle, Mourey, Loïc, Priou, Franck, Rolland, Frédéric, Escudier, Bernard, Albiges, Laurence

Volltext

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised c... von Powles, Thomas, Durán, Ignacio, van der Heijden, Michiel S, Loriot, Yohann, Vogelzang, Nicholas J, De Giorgi, Ugo, Oudard, Stéphane, Retz, Margitta M, Castellano, Daniel, Bamias, Aristotelis, Fléchon, Aude, Gravis, Gwenaëlle, Hussain, Syed, Takano, Toshimi, Leng, Ning, Kadel, Edward E, Banchereau, Romain, Hegde, Priti S, Mariathasan, Sanjeev, Cui, Na, Shen, Xiaodong, Derleth, Christina L, Green, Marjorie C, Ravaud, Alain

Volltext

Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists? von Tisseverasinghe, Steven, Tolba, Marwan, Saad, Fred, Gravis, Gwenaëlle, Bahoric, Boris, Niazi, Tamim

Volltext

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial von Powles, Thomas, Kockx, Mark, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J., Van Der Heijden, Michiel S., Szabados, Bernadett, Pous, Albert Font, Gravis, Gwenaelle, Herranz, Urbano Anido, Protheroe, Andrew, Ravaud, Alain, Maillet, Denis, Mendez, Maria Jose, Suarez, Cristina, Linch, Mark, Prendergast, Aaron, van Dam, Pieter-Jan, Stanoeva, Diana, Daelemans, Sofie, Mariathasan, Sanjeev, Tea, Joy S., Mousa, Kelly, Banchereau, Romain, Castellano, Daniel

Volltext

Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial von Negrier, Sylvie, Rioux-Leclercq, Nathalie, Ferlay, Céline, Gross-Goupil, Marine, Gravis, Gwenaëlle, Geoffrois, Lionel, Chevreau, Christine, Boyle, Helen, Rolland, Frederic, Blanc, Ellen, Ravaud, Alain, Dermeche, Slimane, Flechon, Aude, Albiges, Laurence, Pérol, David, Escudier, Bernard

Volltext

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial von Fizazi, Karim, Prof, Pagliaro, Lance, Prof, Laplanche, Agnes, MD, Fléchon, Aude, MD, Mardiak, Josef, Prof, Geoffrois, Lionnel, MD, Kerbrat, Pierre, Prof, Chevreau, Christine, MD, Delva, Remy, MD, Rolland, Frederic, MD, Theodore, Christine, MD, Roubaud, Guilhem, MD, Gravis, Gwenaëlle, MD, Eymard, Jean-Christophe, MD, Malhaire, Jean-Pierre, MD, Linassier, Claude, Prof, Habibian, Muriel, Martin, Anne-Laure, Journeau, Florence, Reckova, Maria, MD, Logothetis, Christopher, Prof, Culine, Stephane, Prof

Volltext

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer von Pasero, Christine, Gravis, Gwenaëlle, Granjeaud, Samuel, Guerin, Mathilde, Thomassin-Piana, Jeanne, Rocchi, Palma, Salem, Naji, Walz, Jochen, Moretta, Alessandro, Olive, Daniel

Volltext

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study von Flippot, Ronan, Dalban, Cécile, Laguerre, Brigitte, Borchiellini, Delphine, Gravis, Gwénaelle, Négrier, Sylvie, Chevreau, Christine, Joly, Florence, Geoffrois, Lionnel, Ladoire, Sylvain, Mahammedi, Hakim, Rolland, Frédéric, Gross-Goupil, Marine, Deluche, Elise, Priou, Frank, Laramas, Mathieu, Barthélémy, Philippe, Narciso, Bérengère, Houedé, Nadine, Culine, Stéphane, Oudard, Stéphane, Chenot, Marina, Tantot, Florence, Chabaud, Sylvie, Escudier, Bernard, Albiges, Laurence

Volltext

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Ra... von Gravis, Gwenaelle, Boher, Jean-Marie, Joly, Florence, Soulié, Michel, Albiges, Laurence, Priou, Franck, Latorzeff, Igor, Delva, Remy, Krakowski, Ivan, Laguerre, Brigitte, Rolland, Frédéric, Théodore, Christine, Deplanque, Gael, Ferrero, Jean-Marc, Culine, Stéphane, Mourey, Loïc, Beuzeboc, Philippe, Habibian, Muriel, Oudard, Stéphane, Fizazi, Karim

Volltext

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer von Powles, Thomas, Carroll, Danielle, Chowdhury, Simon, Gravis, Gwenaelle, Joly, Florence, Carles, Joan, Fléchon, Aude, Maroto, Pablo, Petrylak, Daniel, Rolland, Frédéric, Cook, Natalie, Balar, Arjun V., Sridhar, Srikala S., Galsky, Matthew D., Grivas, Petros, Ravaud, Alain, Jones, Robert, Cosaert, Jan, Hodgson, Darren, Kozarewa, Iwanka, Mather, Richard, McEwen, Robert, Mercier, Florence, Landers, Dónal

Volltext

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies von Gravis, Gwenaelle, Boher, Jean-Marie, Chen, Yu-Hui, Liu, Glenn, Fizazi, Karim, Carducci, Michael A., Oudard, Stephane, Joly, Florence, Jarrard, David M., Soulie, Michel, Eisenberger, Mario J., Habibian, Muriel, Dreicer, Robert, Garcia, Jorge A., Hussain, Maha H.M., Kohli, Manish, Vogelzang, Nicholas J., Picus, Joel, DiPaola, Robert, Sweeney, Christopher

Volltext

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggreg... von Vale, Claire L, Dr, Burdett, Sarah, MSc, Rydzewska, Larysa H M, BSc, Albiges, Laurence, MD, Clarke, Noel W, Prof, Fisher, David, MSc, Fizazi, Karim, Prof, Gravis, Gwenaelle, MD, James, Nicholas D, Prof, Mason, Malcolm D, Prof, Parmar, Mahesh K B, Prof, Sweeney, Christopher J, MBBS, Sydes, Matthew R, CStat, Tombal, Bertrand, Prof, Tierney, Jayne F, PhD

Volltext

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial von Négrier, Sylvie, Prof, Gravis, Gwenaëlle, MD, Pérol, David, MD, Chevreau, Christine, MD, Delva, Rémy, MD, Bay, Jacques-Olivier, Prof, Blanc, Ellen, MSc, Ferlay, Céline, MSc, Geoffrois, Lionnel, MD, Rolland, Frédéric, MD, Legouffe, Eric, MD, Sevin, Emmanuel, MD, Laguerre, Brigitte, MD, Escudier, Bernard, MD

Volltext

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma von ALBIGES, Laurence, OUDARD, Stéphane, LAGUERRE, Brigitte, LEGOUFFE, Eric, KOHSER, Frédéric, DIETRICH, Pierre-Yves, THEODORE, Christine A, ESCUDIER, Bernard, NEGRIER, Sylvie, CATY, Armelle, GRAVIS, Gwenaëlle, JOLY, Florence, DUCLOS, Brigitte, GEOFFROIS, Lionel, ROLLAND, Frédéric, GUILLOT, Aline

Volltext

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-lab... von Vano, Yann-Alexandre, Elaidi, Réza, Bennamoun, Mostefa, Chevreau, Christine, Borchiellini, Delphine, Pannier, Diane, Maillet, Denis, Gross-Goupil, Marine, Tournigand, Christophe, Laguerre, Brigitte, Barthélémy, Philippe, Coquan, Elodie, Gravis, Gwenaëlle, Houede, Nadine, Cancel, Mathilde, Huillard, Olivier, Beuzeboc, Philippe, Fournier, Laure, Méjean, Arnaud, Cathelineau, Xavier, Doumerc, Nicolas, Paparel, Philippe, Bernhard, Jean-Christophe, de la Taille, Alexandre, Bensalah, Karim, Tricard, Thibault, Waeckel, Thibaut, Pignot, Géraldine, Braychenko, Elena, Caruso, Stefano, Sun, Cheng-Ming, Verkarre, Virginie, Lacroix, Guillaume, Moreira, Marco, Meylan, Maxime, Bougouïn, Antoine, Phan, Letuan, Thibault-Carpentier, Christelle, Zucman-Rossi, Jessica, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Oudard, Stéphane

Volltext